What Researchers Did
Researchers reviewed existing literature on radiotherapy for primary and metastatic malignant melanomas and discussed unconventional treatment methods.
What They Found
The review found that malignant melanomas are generally not very radiosensitive, making surgery the primary treatment. However, the authors noted beneficial responses to radiation therapy in certain circumstances, suggesting its potential utility. They concluded that a prospective study is warranted to define the proper role of radiation therapy across all forms and stages of melanoma.
What This Means for Canadian Patients
For Canadian patients with malignant melanoma, this review reinforces that surgery is the primary treatment, but radiation therapy may offer beneficial responses in specific circumstances. This suggests that radiation could be considered as an adjunctive or palliative option, especially when conventional surgery is not feasible or for metastatic disease.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada nor involved Canadian researchers or patients.
Study Limitations
A key limitation is that this article is a literature review and discussion, not a prospective study, and therefore lacks new empirical data or controlled trial results.